Amy Kruse

General Partner · Satori Capital

Decision makerActive

Email

Verified, deliverable email

Lead Investor | Entrepreneur | Board Director | Scientist | Innovator | International Keynote Speaker

Stages: Series A, Seed
Cheque size: €92k–€4.6M
Freshness: Verified today

Notable investments

Gilgamesh PharmaceuticalsSeries A · $60M · 2026
NextSenseSeries A · $16M · 2025
Feel TherapeuticsConvertible Note · $830K · 2024
Motif NeurotechSeries A · $19M · 2024
TARA MindSeed · $8M · 2024
Dimension InxSeries A · $12M · 2023
MorphoceuticalsSeed · $8M · 2023
CognixionSeed · $12M · 2021

Frequently co-invests with

Blake MycoskieBradley HorowitzGoogle VenturesCyril EbersweilerSOSVDave MessinaPioneer FundDavid BeazleyAlumni VenturesDuncan TurnerSOSVEric BrookAyuh VenturesEsther DysonHealthWorldWeb LLCJohn KuelperAscension VenturesJulia PrakapovichMindrock CapitalKen BelotskyNegev CapitalKunal SethiPrithvi Ventures

Similar investors

Birgitte Gangmark VillmoInvestor, Investinor

Fred TuomiVenture Partner, RET Ventures

Alexandre BartoliniManaging Director, Inveready Technology Investment Group

Axel Sven SpringerAngel, Independent

Ari KorhonenPartner, True Global Ventures

Phyllis WhiteleyVenture Partner, Wildcat Venture Partners

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Amy Kruse? Request removal of this listing.